NCT01118039 2013-08-07Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerNational Cancer Institute (NCI)Phase 2 Unknown41 enrolled